These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18033897)

  • 41. Legislation targeting head shops selling new psychoactive substances and changes in drug-related psychiatric admissions: A national database study.
    Smyth BP; Daly A; Elmusharaf K; McDonald C; Clarke M; Craig S; Cullen W
    Early Interv Psychiatry; 2020 Feb; 14(1):53-60. PubMed ID: 30945460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Harm reduction and illegal drugs: the real debate.
    Mangham C
    Can J Public Health; 2001; 92(3):204-5. PubMed ID: 11496631
    [No Abstract]   [Full Text] [Related]  

  • 43. Is better drug policy a matter of knowing whose pants are on fire? Kirk Dombrowski on Friedman et al.'s "Has United States drug policy failed? And how could we know?".
    Dombrowski K
    Subst Use Misuse; 2012; 47(13-14):1412-3. PubMed ID: 23186425
    [No Abstract]   [Full Text] [Related]  

  • 44. The Global Drug Policy Index: tracking national drug policies.
    Thornton J
    Lancet; 2021 Nov; 398(10313):1788-1789. PubMed ID: 34774137
    [No Abstract]   [Full Text] [Related]  

  • 45. India's National Narcotic Drugs and Psychotropic Substances policy, 2012: a 20th century document in the 21st century.
    Ambekar A; Rao R; Agrawal A
    Int J Drug Policy; 2013 Jul; 24(4):374-5. PubMed ID: 23380179
    [No Abstract]   [Full Text] [Related]  

  • 46. The war on drugs.
    Smith R
    BMJ; 1995 Dec 23-30; 311(7021):1655-6. PubMed ID: 8541746
    [No Abstract]   [Full Text] [Related]  

  • 47. The Philippines' antidrug campaign: Spatial and temporal patterns of killings linked to drugs.
    Atun JML; Mendoza RU; David CC; Cossid RPN; Soriano CRR
    Int J Drug Policy; 2019 Nov; 73():100-111. PubMed ID: 31446164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Some problems with the anti-prohibitionist position on legalization of drugs.
    De Leon G
    J Addict Dis; 1994; 13(2):35-57. PubMed ID: 8204674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Marijuana in Mexico, recreational drug or medicine?
    López-Valdés JC; González-Negrete E; López-Valdés E
    Rev Colomb Psiquiatr (Engl Ed); 2020; 49(1):3-4. PubMed ID: 32081206
    [No Abstract]   [Full Text] [Related]  

  • 50. Education to legality and doping.
    Tripi F; Ciotti L; Lusi A; Romano Spica V;
    Ann Ig; 2019; 31(6):626-641. PubMed ID: 31616906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The clinical connection: drugs and crime.
    Leukefeld CG
    Int J Addict; 1985; 20(6-7):1049-64. PubMed ID: 3908335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Review of international drugs policies is unlikely to change UK stance on criminality.
    Kmietowicz Z
    BMJ; 2014 Oct; 349():g6574. PubMed ID: 25361610
    [No Abstract]   [Full Text] [Related]  

  • 53. Doctors urge public health led approach to drugs policy.
    Gulland A
    BMJ; 2016 Jun; 353():i3387. PubMed ID: 27311946
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmaceutical diversion. A problem for the 1980s.
    Buzzeo R; Williamson RC
    Am Pharm; 1980 Dec; NS20(12):10-4. PubMed ID: 7457353
    [No Abstract]   [Full Text] [Related]  

  • 55. Health and Public Policy to Facilitate Effective Prevention and Treatment of Substance Use Disorders Involving Illicit and Prescription Drugs: An American College of Physicians Position Paper.
    Crowley R; Kirschner N; Dunn AS; Bornstein SS; ; Abraham G; Bush JF; Gantzer HE; Henry T; Kane GC; Lenchus JD; Li JM; McCandless BM; Candler SG
    Ann Intern Med; 2017 May; 166(10):733-736. PubMed ID: 28346947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug abuse and illicit drug trafficking.
    Manderson DR
    Med J Aust; 1998 Jun; 168(12):588-9. PubMed ID: 9673616
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of Schedule I drug laws on neuroscience research and treatment innovation.
    Nutt DJ; King LA; Nichols DE
    Nat Rev Neurosci; 2013 Aug; 14(8):577-85. PubMed ID: 23756634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Policy in matters of drug abuse. Analysis of the report of the expert commission for the revision of the federal law on narcotics (February 1996)].
    Martin J
    Rev Med Suisse Romande; 1996 Aug; 116(8):651-3. PubMed ID: 8848690
    [No Abstract]   [Full Text] [Related]  

  • 59. Has United States drug policy failed? And how could we know?
    R Friedman S; Mateu-Gelabert P; Rossi D
    Subst Use Misuse; 2012; 47(13-14):1402-5. PubMed ID: 23186421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Policy issues and imperatives in the use of opioids to treat pain in substance abusers.
    Joranson DE; Gilson AM
    J Law Med Ethics; 1994; 22(3):215-23. PubMed ID: 7749476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.